Effect of Pneumovax ( R) II vaccination in high-risk individuals on specific antibody and opsonic capacity against specific and non-specific antigen

Author： Huo Z.   Miles J.   Harris T.   Riches P.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.29, 2002-10, pp. : 3532-3534

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity

By Okuda K.   Xin K.-Q.   Tsuji T.   Bukawa H.   Tanaka S.-i.   Koff W.C.   Tani K.   Okuda K.   Honma K.   Kawamoto S.   Hamajima K.   Fukushima J.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1049-1056

Elsevier

Access to resources Recommend Favorite

Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination

By Bautista-Lopez N.   Ward B.J.   Mills E.   McCormick D.   Martel N.   Ratnam S.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1393-1401

Elsevier

Access to resources Recommend Favorite

Prevalence of non-specific health symptoms in South Australia

By Heyworth Jane   McCaul Kieran  

International Journal of Environmental Health Research, Vol. 11, Iss. 4, 2001-11 ,pp. : 291-298

Taylor & Francis Ltd

Access to resources Recommend Favorite

Protection of rainbow trout against infectious hematopoietic necrosis virus four days after specific or semi-specific DNA vaccination

By LaPatra S.E.   Corbeil S.   Jones G.R.   Shewmaker W.D.   Lorenzen N.   Anderson E.D.   Kurath G.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 4011-4019

Elsevier

Access to resources Recommend Favorite

BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa - A non-specific beneficial effect of BCG?

By Garly M.-L.   Martins C.L.   Bale C.   Balde M.A.   Hedegaard K.L.   Gustafson P.   Lisse I.M.   Whittle H.C.   Aaby P.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2782-2790

Elsevier

Access to resources Recommend Favorite